https://prabadinews.com/
Email
weborders@prabadincorp.com
Call us
+1 (786)-332-3938
Home
Blog
Latest Post
Product Catalog
X
Health
September 3, 2025
Empowering Pharmacists in the Management of Patients With Urothelial Cancer
Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients…
Health
September 3, 2025
CMS Mailing Restrictions and Their Impact on Oncology Care Delivery
David Eagle, MD, Chair of Legislative Affairs and Patient Advocacy, explains how CMS’s ban on community oncology practices mailing medications…
Health
September 3, 2025
Regardless of Kidney Function, Abelacimab Consistently Reduced Bleeding Risk in Patients With AF
Compared with rivaroxaban, abelacimab significantly lowered bleeding risk in patients (AF) regardless of kidney function.
Health
September 2, 2025
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
Abemaciclib significantly enhances overall survival in high-risk HR+, HER2- early breast cancer, establishing a new standard of care.
Health
September 2, 2025
Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma
Subcutaneous bortezomib shows fewer adverse effects in multiple myeloma treatment compared to intravenous administration, enhancing patient outcomes.
Health
September 2, 2025
FDA to Waive Clinical Efficacy Studies for Monoclonal Antibody Biosimilars
This decision is believed to redefine how biological drugs will be developed, approved, and made affordable for patients.
Health
September 2, 2025
Expert: ECAPS Act Could Sustain Pharmacists’ Public Health Role Postpandemic
Susan Cantrell, RPh, MHL, CAE, highlights the Equitable Community Access to Pharmacy Services (ECAPS) Act as the top federal priority…
Health
September 2, 2025
Fast-Melt Tablets: A New Era in Drug Delivery
Fast-melt tablets (FMT) in drug delivery enhanced patient compliance and therapeutic response.
Health
September 2, 2025
FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab
The approval of 2 denosumab biosimilars, Bildyos and Bilprevda, enhances access to affordable bone health treatments for patients.
Health
September 2, 2025
New Clinical Guidance Recommends Vaccines to Protect Cardiovascular Patients From Respiratory Illness
Vaccination is vital for adults with heart disease to prevent severe respiratory illnesses like RSV, influenza, and COVID-19, enhancing overall…
1
...
4
5
6
7
8
...
83